Skip to main content

Slynd FDA Approval History

Last updated by Judith Stewart, BPharm on July 1, 2019.

FDA Approved: Yes (First approved May 23, 2019)
Brand name: Slynd
Generic name: drospirenone
Dosage form: Tablets
Company: Exeltis
Treatment for: Birth Control

Slynd (drospirenone) is a progestin oral contraceptive for birth control.

Development timeline for Slynd

DateArticle
Jun  6, 2019Approval Exeltis USA, Inc. Announces the Approval of Slynd (drospirenone), the First and Only Progestin-Only Pill Providing Pregnancy Prevention with a 24/4 Dosing Regimen and 24-hour Missed Pill Window
Nov 29, 2018FDA Accepts Filing of New Estrogen-free Oral Contraceptive Slinda (drospirenone) Developed by Exeltis

See also

Slynd (drospirenone) Consumer information

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer